Real World Evidence is key for pharma organizations in drug development- 5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference

Real World Evidence is key for pharma organizations in drug development- 5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference

5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference (Time Zone – EST) to be held on 19th – 22nd October 2021 will host industry giants like Sarepta Therapeutics, Idorsia Pharmaceuticals, Food and Drug Administration (FDA), AveXis, Rafael Pharmaceuticals, PicnicHealth, Dedalus Group, RTI Health Solutions, Bluebird Bio, Seagen, Takeda, Takeda Pharmaceuticals, Novartis, OM1 and many more. The global real-world evidence market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%. The growth of this…

Read More

BMS, Takeda, Celgene, Boehringer-Ingelheim & Biogen will Speak at 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress

BMS, Takeda, Celgene, Boehringer-Ingelheim & Biogen will Speak at 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress

Boston, USA, 5th September – 2nd Annual MarketsandMarkets Real-World Data & Life Science Analytics Congress will be hosting industry giants like Bristol Myers Squibb, Takeda, Genentech, Boehringer-Ingelheim, Celgene and Biogen will take place at the DoubleTree by Hilton Boston-Downtown on 25th & 26th October 2019. Presenting 20+ RWD case studies, the congress aims to discuss accelerating the adoption of Real-world Evidence, capabilities of newer technologies for evidence generation within the industry. The event agenda will focus on key aspects such as Real-World Evidence Methodologies, FDA’ strategic framework, Applications of Artificial Intelligence…

Read More

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

Technologies Transforming Real-World Evidence (RWE) Evidence in the Pharmaceutical Industry

As new drugs are emerging every day, it is very important to ensure that the patients get right and effective treatment. One such step can be taken from Real World Evidence (RWE). In simple words, Real World Evidence means data and information collected outside of a clinical trial. This data can be electronic medical records, medical charts or other medical claims to assess patient outcomes. It is made sure that the patient’s identity is removed from the previous data to maintain the patient’s privacy. However, today’s real-world evidence data is…

Read More